A

Axsome Therapeutics

D
AXSM
USD
-0.34
(-0.3477%)
Market Closed
23,148.00
حجم التداول
-5.62
الربح لكل سهم
-
العائد الربحي
-14.810030
P/E
4,677,619,977.25
حجم السوق
اليوم
-0.3477%
1 اسبوع
7.478%
1 شهر
14.097%
6 اشهر
25.807%
12 اشهر
55.423%
بداية السنة
22.409%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Axsome Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
هل تحتاج مساعدة او لديك استفسار؟